AJP - Renal AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 286: F546-F551, 2004. First published December 16, 2003; doi:10.1152/ajprenal.00338.2003
0363-6127/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/3/F546    most recent
00338.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (37)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Facemire, C. S.
Right arrow Articles by Arendshorst, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Facemire, C. S.
Right arrow Articles by Arendshorst, W. J.

Expression and relative abundance of short transient receptor potential channels in the rat renal microcirculation

Carie S. Facemire,1 Peter J. Mohler,2 and William J. Arendshorst1

1Department of Cell and Molecular Physiology and Program in Integrative Vascular Biology, University of North Carolina at Chapel Hill, Chapel Hill 27599-7545; and 2Howard Hughes Medical Institute and Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710

Submitted 23 September 2003 ; accepted in final form 15 November 2003


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
In the resistance vessels of the renal microcirculation, store- and/or receptor-operated calcium entry contribute to the rise in vascular smooth muscle cell (VSMC) intracellular calcium concentration in response to vasoconstrictor hormones. Short transient receptor potential (TRPC) channels are widely expressed in mammalian tissues and are proposed mediators of voltage-independent cation entry in multiple cell types, including VSMCs. The seven members of the TRPC gene family (TRPC1-7) encode subunit proteins that are thought to form homo- and heterotetrameric channels that are differentially regulated depending on their subunit composition. In the present study, we demonstrate the relative abundance of TRPC mRNA and protein in freshly isolated rat renal resistance vessels, glomeruli, and aorta. TRPC1, 3, 4, 5, and 6 mRNA and protein were detected in both renal resistance vessels and aorta, whereas TRPC2 and TRPC7 mRNA were not expressed. TRPC1, 3, 5, and 6 protein was present in glomeruli. TRPC3 and TRPC6 protein levels were significantly greater in the renal resistance vessels, about six- to eightfold higher than in aorta. These data suggest that TRPC3 and TRPC6 may play a role in mediating voltage-independent calcium entry in renal resistance vessels that is functionally distinct from that in aorta.

vascular smooth muscle cells; resistance vessels; aorta; store-operated channel; receptor-operated channel

ALTHOUGH L-TYPE VOLTAGE-DEPENDENT calcium channels have been the focus of much study on the regulation of vascular reactivity, voltage-independent cation channels represent an important component of calcium entry in cells of the systemic and renal vasculature as well. In the preglomerular resistance vessels (interlobular arteries and afferent arterioles), non-L-type calcium entry contributes to vascular smooth muscle cell (VSMC) calcium responses to norepinephrine (6, 27) and vasopressin (8), vasoactive hormones that regulate renal blood flow and glomerular filtration rate. Store-operated calcium influx has been shown to negatively regulate renin secretion by juxtaglomerular cells (28). In VSMCs of conduit arteries such as aorta, calcium entry through store- and/or receptor-operated channels (SOCs, ROCs) is activated by norepinephrine and endothelin-1 (10, 30, 38). Calcium entry through these SOCs and ROCs also modulates vascular endothelial and glomerular mesangial cell function (20, 24, 26). These receptor-mediated calcium entry pathways have been incompletely characterized due to a lack of pharmacological agents able to discriminate between the function of SOCs and ROCs. Identification of the molecular components of these cation channels in renal resistance vessels would permit genetic manipulation and more detailed investigation into the regulation of these important calcium entry pathways.

The transient receptor potential (TRP) superfamily comprises a diverse group of ion channel proteins that are expressed in many tissues and cell types. Drosophila TRP, the first identified member of this gene family, functions as a light-sensitive, calcium-permeable nonselective cation channel essential to phototransduction (22, 40). Studies in Drosophila indicate that TRP is the target of a phosphoinositide signaling cascade downstream of a G protein-coupled receptor, suggesting that Drosophila phototransduction may be analogous to the widespread process of receptor-mediated calcium entry. These studies prompted efforts to identify vertebrate TRP homologs, which have recently been implicated in mediating diverse processes including olfaction, vasorelaxation, and responses to mechanical, chemical, and osmotic stimuli (22).

Members of the mammalian short (canonical) TRP (TRPC) family of channels, those most closely related to Drosophila TRP, have recently been implicated in mediating store- and receptor-operated calcium entry in various cell types, including vascular endothelial and smooth muscle cells (14, 24, 32, 36). These channels appear to be widely expressed in smooth muscles, and evidence suggests that the specific complement of TRPC proteins present may govern the mechanisms by which these channels are regulated in a given cell type (22, 40). TRPCs have been shown to mediate agonist-induced voltage-independent calcium entry in native VSMCs (14, 36) as well as myogenic tone in isolated resistance arteries (35). Aortic and lung vascular endothelial cells of TRPC4 knockout mice display significantly reduced store-operated calcium entry, confirming the role of TRPC4 in endothelial nitric oxide-mediated regulation of vascular tone and thrombin-induced increases in microvascular permeability (9, 32). Based on a growing body of evidence confirming the role of TRPCs in the regulation of endothelial and VSMC function, we investigated the presence of these channels in the renal microcirculation, as they represent exciting new targets in the study and treatment of renal and cardiovascular disease. In this study, we report the expression and relative abundance of the seven TRPC gene products in freshly isolated renal and nonrenal vascular tissues.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Tissue isolation. The iron oxide sieving technique, previously described in our laboratory (5, 15), was used to isolate preglomerular resistance vessels and glomeruli from 5-wk-old male Sprague-Dawley rats maintained in the Chapel Hill breeding colony. All procedures were performed in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals and in compliance with the guidelines and practices of the University of North Carolina at Chapel Hill Institutional Animal Care and Use Committee. Two rats were used for each preparation. The isolation of preglomerular vessels and glomeruli was performed essentially as described previously (5, 15), with the following exceptions. After the tissue was passed through a 100-µm sieve, the preglomerular vessels were further purified with another magnet separation and treated with collagenase (type 1, Worthington Biochemical, Lakewood, NJ; 0.14-0.20 mg/ml in PBS) for 30 min at 35-37°C. The preparation was then passed through a 22-gauge needle to further separate vessels from tubule fragments, and a magnet was used to isolate the final preparation of preglomerular resistance vessels, consisting of short segments of interlobular arteries and afferent arterioles. Preglomerular resistance vessels and glomeruli were rinsed in PBS by centrifugation and resuspended in TriReagent (Sigma, St. Louis, MO) or RNALater (Ambion, Austin, TX) for extraction of RNA or in Laemmli sample buffer (50 mM Tris·HCl, 100 mM dithiothreitol, 2% SDS, 10% glycerol) for SDS-PAGE.

Segments of thoracic aorta and brain (cerebrum) were obtained from rats immediately after removal of the kidneys. Aortic segments were quickly cleaned of excess connective tissue and then cut lengthwise. The luminal surface of the vessel was gently scraped with forceps to remove endothelium. Aorta and brain tissue were stored in RNALater for extraction of RNA or ice-cold PBS for SDS-PAGE.

RT-PCR. Total RNA was extracted from freshly isolated preglomerular resistance vessels, aorta, and brain using TriReagent (Sigma), according to the manufacturer's protocol. RNA was DNase treated using DNA-free (Ambion) to remove genomic DNA contamination. RNA yield was quantified by UV spectrophotometry, and integrity was verified by 1% agarose gel electrophoresis and staining with ethidium bromide. Only RNA with A260/280 > 1.7 and displaying no significant degradation was used for reverse transcription.

cDNAs were synthesized from 3 µg of total RNA using random hexamers and SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA). "No RT" samples lacking reverse transcriptase were prepared during each RT reaction for use as negative controls during PCR. TRPC1-7 primers were synthesized (Qiagen/Operon, Valencia, CA) based on published sequences (21). cDNA template (3 µl) was added to a 50-µl PCR reaction mixture consisting of 20 mM Tris·HCl (pH 8.4), 50 mM KCl, 2 mM MgCl2, 200 µM dNTPs, 1 U of Platinum Taq DNA polymerase (Invitrogen), and 0.2 nmol of each primer. cDNA templates and no RT samples were amplified by PCR for 35 cycles of 94°C for 1 min, 50-59°C for 1 min, and 72°C for 2 min; this was followed by a final extension step at 72°C for 10 min. PCR products were visualized by 1.5% agarose gel electrophoresis and staining with ethidium bromide.

Real-time quantitative PCR. Real-time quantitative PCR was performed using the fluorogenic 5'-exonuclease assay (12). TRPC primers and dual-labeled probes (5'-FAM, 3'-TAMRA) were designed from the coding regions of the TRPC genes using Primer3 software (Whitehead Institute, Massachusetts Institute of Technology) and prepared by the oligonucleotide synthesis core facility at the University of North Carolina at Chapel Hill (Table 1). PCR reactions were performed in duplicate on a RotorGene 3000 multiplexing system (Corbett Research, Sydney, Australia). cDNA and negative control (no RT, water) templates (1 µl) were added to a 20-µl multiplex PCR reaction mixture consisting of 20 mM Tris·HCl (pH 8.4), 50 mM KCl, 5.5 mM MgCl2, 800 µM dNTPs, 1 U of Platinum Taq DNA polymerase (Invitrogen), 30 nM 18S ribosomal RNA (18S rRNA) forward and reverse primers (Applied Biosystems, Foster City, CA), 200 nM 18S rRNA TaqMan probe (5'-VIC, 3'-TAMRA, Applied Biosystems), 300-900 nM forward and reverse TRPC primers, and 150-250 nM TRPC probes. TRPC expression was quantified using RotorGene software (Corbett Research) and the two standard curve method for relative quantitation (4). Briefly, a five-point dilution series of positive control (brain) cDNA was prepared, and standard curves of threshold cycle (Ct) vs. relative template concentration were generated for the gene of interest (TRPC) and housekeeping gene (18S rRNA). Template concentrations of unknown samples were then determined, based on their Ct values, from these standard curves. Data are expressed as a ratio of TRPC expression to 18S rRNA expression in the same sample.


View this table:
[in this window]
[in a new window]
  		Table 1. Oligonucleotide sequences of primers and dual-labeled probes used for real-time RT-PCR

 

SDS-PAGE and immunoblotting. TRPC proteins examined were difficult to detect by conventional Western blot techniques, specifically using minigels, chemiluminescence, and conventional Tween-20/Tris-buffered saline (TTBS) washing buffer. Therefore, we performed quantitative Western blotting using 18 x 16-cm Fairbanks gradient gels. Additionally, we used125I-labeled protein A to detect TRPC polypeptides instead of conventional enhanced chemiluminescence (ECL) techniques.

Protein concentrations were determined by Bradford assay (3) using bovine serum albumin as a standard, and 40 µg of sample were analyzed for each tissue. PAGE was performed using 0.2% SDS in the buffers of Fairbanks et al. (7) and 3.5-17% exponential gradient gels. Electrophoresed proteins were transferred to nitrocellulose and blotted with affinity-purified antibodies against specific TRPC proteins: rabbit anti-TRPC1 [90 kDa, antibody against QLYKDGYTSKEQKDC (residues 557-571); Alomone Labs, Jerusalem, Israel; 1:500], rabbit anti-TRPC3 [107 kDa, antibody against residues HKLSEKLNPSVLRC (822-835); Alomone; 1:500], rabbit anti-TRPC4 [95-100 kDa, antibody against residues KEKHAHEEDSSIIDYDL (943-958); Alomone; 1:500], rabbit anti-TRPC5 (100 kDa, antibody against residues HKWGDGQEEQVTTRL; Alomone; 1:300), or rabbit anti-TRPC6 [105 kDa, against residues RRNESQKYLLMDELG (24-38); Alomone; 1:500]. Blots were analyzed with antibody against {beta}-actin (Sigma) as a loading control. Blots were washed, incubated with 125I-labeled protein A, washed again, and analyzed by phosphorImaging.

As we observed nonspecific bands using commercial antibodies with TTBS wash buffer, we changed our washing conditions, with the first washes in 150 mM NaCl, 10 mM phosphate buffer, 1 mM EDTA, 0.2% Triton X-100, and 1 mM NaN3. The blots were then washed in 150 mM NaCl, 10 mM phosphate buffer, 1 mM EDTA, 1 mM NaN3, 2 M urea, 0.2 M glycine, and 1% Triton X-100. Only using these conditions were we able to convincingly confirm distinct TRPC polypeptides at the correct molecular weight with little or no nonspecific bands. No bands corresponding to TRPC polypeptides were detected using rabbit nonimmune serum, and specific TRPC bands were absent when antibodies were preincubated with control antigen peptides.

Statistical analysis. Data are presented as means ± SE. SigmaStat (SPSS, Chicago, IL) software was used for statistical analysis. Statistical significance was evaluated by one-way ANOVA and Holm-Sidak post hoc test for multiple comparisons. Kruskal-Wallis one-way ANOVA on ranks was used to analyze data sets with nonnormal distributions. A value of P < 0.05 was considered significant.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
RT-PCR analysis of brain, aorta, and renal preglomerular resistance vessels produced amplicons of the predicted size for each TRPC family member (Fig. 1). Transcripts for all TRPC genes were detected in brain, although TRPC2 was barely detectable. The low level of TRPC2 mRNA in brain was not surprising, because TRPC2 expression has only been demonstrated in a limited number of tissues, including mouse sperm and the rat vomeronasal organ (22). Both aorta and renal preglomerular resistance vessels express mRNA for TRPC1, 3, 4, 5, and 6, whereas TRPC2 and TRPC7 transcripts were not detected. Three splice variants of TRPC6 have been cloned in rat: TRPC6A (full length), TRPC6B (missing NH2-terminal 56 amino acids), and TRPC6C (missing NH2-terminal 56 amino acids and COOH-terminal 68 amino acids) (37). Therefore, the two amplicons observed in preglomerular resistance vessels likely represent different TRPC6 isoforms.



View larger version (71K):
[in this window]
[in a new window]
  		Fig. 1. RT-PCR analysis of short transient receptor potential (TRPC) 1-7 mRNA expression in rat brain (cerebrum), aorta, and preglomerular resistance vessels (PRVs). PCR products (10 µl/lane) were visualized by agarose gel electrophoresis and staining with ethidium bromide. No RT, negative control; brain, positive control.

 

To determine the relative abundance of the five TRPC transcripts expressed in aorta and renal resistance vessels, real-time quantitative RT-PCR was performed using RNA from these freshly isolated tissues. Figure 2A shows that TRPC3 mRNA is at least threefold more abundant than TRPC1, TRPC5, and TRPC6, whereas TRPC4 expression is quite low in preglomerular resistance vessels. In aorta, TRPC1 and TRPC6 mRNAs predominate, showing significantly higher expression levels than TRPC3, 4, and 5 (Fig. 2B). Interestingly, there is no significant difference in mRNA expression of TRPC1, 5, and 6 between preglomerular resistance vessels and aorta, whereas TRPC3 mRNA is nearly seven times more abundant in the renal resistance vessels.



View larger version (26K):
[in this window]
[in a new window]
  		Fig. 2. Relative TRPC1, 3, 4, 5, and 6 mRNA expression levels in renal PRVs, aorta, and brain, determined by real-time quantitative RT-PCR. A: relative abundance of TRPC transcripts in PRVs. *P < 0.01 vs. TRPC1, 4, 5, and 6. B: relative comparison of TRPC mRNA levels in brain (positive control, gray bars), aorta (open bars), and renal PRVs (filled bars). TRPC expression was normalized to 18S ribosomal RNA (18S rRNA) expression in the same template. Experiments were repeated using fresh tissue preparations from 4 different sets of animals (n = 4). Data are means ± SE. Statistical analysis was performed using 1-way ANOVA and Holm-Sidak method for multiple comparisons. *P <= 0.05 vs. aorta TRPC3, 4, and 5. #P < 0.05 vs. aorta TRPC3.

 

TRPC protein levels in aorta, glomeruli, and preglomerular resistance vessels were assessed by semiquantitative immunoblotting, which yielded bands of the appropriate molecular masses for all antibodies tested (TRPC1, 90 kDa; TRPC3, 107 kDa; TRPC4, 95-100 kDa; TRPC5, 100 kDa; TRPC6, 105 kDa; Fig. 3A, left). All bands were absent in control experiments where antibody was incubated with antigen peptide (Fig. 3A, right). Low levels of all TRPC polypeptides examined were detected in rat aorta (Fig. 3A). Significantly, we observed an approximately eightfold increase in TRPC3 expression in preglomerular resistance vessels compared with aorta (Fig. 3B). TRPC1 and TRPC6 protein levels are also significantly greater in preglomerular resistance vessels than in aorta, unlike the mRNA expression pattern. The pattern of glomerular TRPC expression is similar to that in aorta, with the exception of TRPC5, which is more abundant in glomeruli than in aorta.



View larger version (27K):
[in this window]
[in a new window]
  		Fig. 3. TRPC protein expression in renal and nonrenal vascular tissues. Immunoblotting experiments were performed on cell lysates prepared from freshly isolated rat aorta, glomeruli, and PRVs. A: representative blots for TRPC1, 3, 4, 5, and 6 show bands of 90, 107, 93, 100, and 105 kDa, respectively, for all antibodies tested (left). Bottom, left: {beta}-actin was used as a protein loading control. Right: blots using antibodies in the presence of control antigen peptides. B: relative TRPC protein levels in renal PRVs (filled bars), glomeruli (gray bars), and aorta (open bars), determined by phosphorImaging of125I-labeled blots. TRPC protein levels were corrected for {beta}-actin and expressed as fold expression relative to aorta. Experiments were repeated using tissues from 3 different sets of animals (n = 3). Data are means ± SE. Statistical analysis was performed using 1-way ANOVA and Holm-Sidak method for multiple comparisons. *P < 0.05 vs. aorta (open bars).

 


   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
TRPCs are known to be present in VSMCs of several vascular beds, including pulmonary artery (21, 23, 34), aorta (36), portal vein (14), renal artery (34), cerebral arteries (35), and pial arterioles (36). However, the relative abundances of the seven TRPC family members have not been determined quantitatively in any freshly isolated resistance vessels. The only evidence for TRPC expression in the renal microcirculation consists of immunohistochemical localization of TRPC1 in rat afferent and efferent arterioles; the presence of other TRPC proteins was not investigated in this study (29). In our study, we present a comprehensive characterization of TRPC expression in freshly isolated resistance and conduit vessels of the renal and systemic circulations as well as in glomeruli. Based on these mRNA and protein expression data, it is clear that TRPC3 is the predominant TRPC gene product expressed in renal preglomerular resistance vessels and that TRPC6 is also abundant. This expression pattern differs markedly from that in aorta, where TRPC1 and TRPC6 predominate, although at lower protein levels than those found in renal resistance vessels.

We cannot exclude the possibility that some TRPC expression observed in the preglomerular resistance vessels is contributed by endothelial cells, because the fresh renal resistance vessel preparation used in these studies contains not only VSMCs but also vascular endothelial cells. However, we can be reasonably certain that the expression pattern observed in preglomerular resistance vessels is primarily due to VSMC TRPC expression, because there are no reports of elevated TRPC3 or TRPC6 in freshly isolated vascular endothelial cells, where TRPC1 and TRPC4 appear to predominate (1, 11, 18). Our belief that TRPC levels in the preglomerular resistance vessel preparation are a reflection of VSMC TRPC expression is supported by immunofluorescence localization of TRPC3 and TRPC6 in cerebral resistance arteries (35). In this study, the pattern of TRPC3 and TRPC6 immunofluorescent labeling is consistent with intact VSMC morphology. The freshly isolated glomerular preparation used in our study also contains multiple cell types, including glomerular mesangial and endothelial cells as well as podocytes. There is functional evidence for the presence of SOCs and/or ROCs in cultured mesangial cells (20, 26) and a few studies that suggest non-L-type channels may be activated by vasoactive agonists in podocytes (13, 25). However, compelling evidence for these calcium entry pathways in glomerular endothelial cells is lacking. It is therefore probable that TRPC expression in glomeruli is contributed primarily by mesangial cells and possibly podocytes, where these proteins likely mediate store- and/or receptor-operated calcium entry.

In preglomerular resistance vessels, TRPC1, 3, 4, and 5 protein levels correlate well with the observed mRNA expression pattern. However, TRPC6 protein levels are much greater than in aorta, whereas TRPC6 mRNA levels are similar between the two tissues (Figs. 2B and 3B). Because the primers used for quantitative RT-PCR in the present study amplify all three TRPC6 splice variants (TRPC6A, B, and C), but the TRPC6 antibody used does not recognize TRPC6C, the observed mRNA/protein discrepancy could reflect a difference in TRPC6C expression between aorta and renal resistance vessels rather than a difference in total TRPC6 protein abundance. Alternatively, TRPC6 mRNA and/or protein may display increased stability in preglomerular resistance vessels, suggesting that TRPC6 mRNA is subject to posttranscriptional and/or posttranslational modification via an unknown regulatory mechanism.

The abundance of TRPC3 in preglomerular resistance vessels compared with that in aorta suggests an important role for TRPC3 in the renal resistance vessels that may be absent in larger conduit arteries. TRPC3 mRNA has been detected in freshly isolated VSMCs from main renal artery, but its abundance relative to other TRPCs was not determined (34). To date, a functional role for endogenous TRPC3 has been demonstrated only in the brain, where it appears to be involved in brain-derived nerve growth factor-induced neuronal differentiation and plasticity (19). Although there is evidence that TRPC3 expressed in DT40 cells can be activated by store depletion, the majority of data support a receptor-operated mechanism of activation (33). Activation of TRPC3 by diacylglycerol (DAG) has been confirmed by several groups using different in vitro expression systems (33). Several studies also suggest that TRPC3 activity may be regulated through interactions with the inositol 1,4,5-trisphosphate receptor (2, 16, 17, 30) and calmodulin (31, 39).

TRPC6 is also reported to form a ROC that is activated by DAG analogs in vitro (33). Such an activation mechanism appears to be absent for the TRPC6B splice variant, suggesting that a sequence contained in the 56 amino acids missing from the TRPC6B NH2 terminus is responsible for activation by DAG (37). Interestingly, protein kinase C appears to negatively regulate TRPC6 channel function in vitro (37) and is also thought to have a similar action on TRPC3 (33). Inoue et al. (14) recently reported that TRPC6 is a component of the {alpha}1-adrenoceptor-activated nonselective cation channel in rabbit portal vein myocytes, which appears to function as a store-independent calcium entry pathway.

Based on the current literature and the unique TRPC expression pattern observed in renal preglomerular resistance vessels, we speculate that TRPC3 and TRPC6 may form functional ROCs in VSMCs of the renal microcirculation. Our findings are significant in that this TRPC expression pattern appears to be specific to either renal vasculature or to small-diameter resistance vessels, or perhaps both. These data provide a basis for further functional studies investigating the physiological regulation of voltage-independent calcium entry pathways in preglomerular VSMCs.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
These studies were supported by National Heart, Lung, and Blood Institute Grants HL-02334 and HL-69768. P. J. Mohler is a postdoctoral fellow in the laboratory of Vann Bennett.


   FOOTNOTES
 

Address for reprint requests and other correspondence: W. J. Arendshorst, Dept. of Cell and Molecular Physiology, Univ. of North Carolina at Chapel Hill, CB#7545, School of Medicine, 6341B Medical Biomolecular Research Bldg., Chapel Hill, NC 27599-7545 (E-mail: arends{at}med.unc.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Antoniotti S, Lovisolo D, Fiorio Pla A, and Munaron L. Expression and functional role of bTRPC1 channels in native endothelial cells. FEBS Lett 510: 189-195, 2002.[CrossRef][Web of Science][Medline]
  2. Boulay G, Brown DM, Qin N, Jiang M, Dietrich A, Zhu MX, Chen Z, Birnbaumer M, Mikoshiba K, and Birnbaumer L. Modulation of Ca2+ entry by TRP-binding polypeptides of the inositol 1,4,5-trisphosphate receptor (IP3R). Evidence for roles of TRP and the IP3R in store depletion-activated Ca2+ entry. Proc Natl Acad Sci USA 96: 14955-14960, 1999.[Abstract/Free Full Text]
  3. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.[CrossRef][Web of Science][Medline]
  4. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription PCR assays. J Mol Endocrinology 25: 169-193, 2000.[Abstract]
  5. Chatziantoniou C and Arendshorst WJ. Angiotensin receptor sites in renal vasculature of rats developing genetic hypertension. Am J Physiol Renal Fluid Electrolyte Physiol 265: F853-F862, 1993.[Abstract/Free Full Text]
  6. Facemire CS and Arendshorst WJ. Norepinephrine (NE) stimulates voltage-dependent and -independent calcium entry pathways in renal resistance vessels-possible role of short transient receptor potential channels (TRPC) (Abstract). FASEB J 17: A924, 2003.
  7. Fairbanks G, Steck TL, and Wallach DF. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 10: 2606-2617, 1971.[CrossRef][Medline]
  8. Fellner SK and Arendshorst WJ. Capacitative calcium entry in smooth muscle cells from preglomerular vessels. Am J Physiol Renal Physiol 277: F533-F542, 1999.[Abstract/Free Full Text]
  9. Freichel M, Suh SH, Pfeifer A, Schweig U, Trost C, Weissgerber P, Biel M, Philipp S, Freise D, Droogmans G, Hofmann F, Flockerzi V, and Nilius B. Lack of an endothelial store-operated Ca2+ current impairs agonist-dependent vasorelaxation in TRP4-/- mice. Nature Cell Biol 3: 121-127, 2001.[CrossRef][Web of Science][Medline]
  10. Furutani H, Zhang XF, Iwamuro Y, Lee K, Okamoto Y, Takikawa O, Fukao M, Masaki T, and Miwa S. Ca2+ entry channels involved in contractions of rat aorta induced by endothelin-1, noradrenaline, and vasopressin. J Cardiovasc Pharmacol 40: 265-276, 2002.[CrossRef][Web of Science][Medline]
  11. Groschner K, Hingel S, Lintschinger B, Balzer M, Romanin C, Zhu X, and Schreibmayer W. Trp proteins form store-operated cation channels in human vascular endothelial cells. FEBS Lett 437: 101-106, 1998.[CrossRef][Web of Science][Medline]
  12. Heid CA, Stevens J, Livak KJ, and Williams PM. Real time quantitative PCR. Genome Res 6: 986-994, 1996.[Abstract/Free Full Text]
  13. Huber TB, Gloy J, Henger A, Schollmeyer P, Greger R, Mundel P, and Pavenstadt H. Catecholamines modulate podocyte function. J Am Soc Nephrol 9: 335-345, 1998.[Abstract]
  14. Inoue R, Okada T, Onoue H, Hara Y, Shimizu S, Naitoh S, Ito Y, and Mori Y. The transient receptor potential protein homologue TRP6 is the essential component of vascular {alpha}1-adrenoceptor-activated Ca2+-permeable cation channel. Circ Res 88: 325-332, 2001.[Abstract/Free Full Text]
  15. Iversen BM and Arendshorst WJ. Angiotensin II and vasopressin stimulate calcium entry in freshly isolated afferent arteriolar smooth muscle cells. Am J Physiol Renal Physiol 274: F498-F508, 1998.[Abstract/Free Full Text]
  16. Kiselyov K, Mignery GA, Zhu MX, and Muallem S. The N-terminal domain of the IP3 receptor gates store-operated hTrp3 channels. Mol Cell 4: 423-429, 1999.[CrossRef][Web of Science][Medline]
  17. Kiselyov K, Xu X, Mozhayeva G, Kuo T, Pessah I, Mignery G, Zhu X, Birnbaumer L, and Muallem S. Functional interaction between InsP3 receptors and store-operated Htrp3 channels. Nature 396: 478-482, 1998.[CrossRef][Medline]
  18. Kohler R, Brakemeier S, Kuhn M, Degenhardt C, Buhr H, Pries A, and Hoyer J. Expression of ryanodine receptor type 3 and TRP channels in endothelial cells: comparison of in situ and cultured human endothelial cells. Cardiovasc Res 51: 160-168, 2001.[CrossRef][Web of Science][Medline]
  19. Li HS, Xu XZS, and Montell C. Activation of a TRPC3-dependent cation channel through the neurotrophin BDNF. Neuron 24: 261-273, 1999.[CrossRef][Web of Science][Medline]
  20. Ma R, Smith S, Child A, Carmines PK, and Sansom SC. Store-operated Ca2+ channels in human glomerular mesangial cells. Am J Physiol Renal Physiol 278: F954-F961, 2000.[Abstract/Free Full Text]
  21. McDaniel SS, Platoshyn O, Wang J, Yu Y, Sweeney M, Krick S, Rubin LJ, and Yuan JXJ. Capacitative Ca2+ entry in agonist-induced pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol 280: L870-L880, 2001.[Abstract/Free Full Text]
  22. Minke B and Cook B. TRP channel proteins and signal transduction. Physiol Rev 82: 429-472, 2002.[Abstract/Free Full Text]
  23. Ng LC and Gurney AM. Store-operated channels mediate Ca2+ influx and contraction in rat pulmonary artery. Circ Res 89: 923-929, 2001.[Abstract/Free Full Text]
  24. Nilius B, Droogmans G, and Wondergem R. Transient receptor potential channels in endothelium: solving the calcium entry puzzle? Endothelium 10: 5-15, 2003.[CrossRef][Web of Science][Medline]
  25. Nitschke R, Henger A, Ricken S, Gloy J, Muller V, Greger R, and Pavenstadt H. Angiotensin II increases the intracellular calcium activity in podocytes of the intact glomerulus. Kidney Int 57: 41-49, 2000.[CrossRef][Web of Science][Medline]
  26. Nutt LK and O'Neil RG. Effect of elevated glucose on endothelin-induced store-operated and nonstore-operated calcium influx in renal mesangial cells. J Am Soc Nephrol 11: 1225-1235, 2000.[Abstract/Free Full Text]
  27. Salomonsson M and Arendshorst WJ. Calcium recruitment in renal vasculature: NE effects on blood flow and cytosolic calcium concentration. Am J Physiol Renal Physiol 276: F700-F710, 1999.[Abstract/Free Full Text]
  28. Schweda F, Riegger GA, Kurtz A, and Kramer BK. Store-operated calcium influx inhibits renin secretion. Am J Physiol Renal Physiol 279: F170-F176, 2000.[Abstract/Free Full Text]
  29. Takenaka T, Suzuki H, Okada H, Inoue T, Kanno Y, Ozawa Y, Hayashi K, and Saruta T. Transient receptor potential channels in rat renal microcirculation: actions of angiotensin II. Kidney Int 62: 558-565, 2002.[CrossRef][Web of Science][Medline]
  30. Tanaka Y, Imai T, Igarashi T, Takayanagi K, Otsuka K, Yamaki F, Tanaka H, and Shigenobu K. Comparison of the Ca2+ entry channels responsible for mechanical responses of guinea-pig aorta to noradrenaline and thapsigargin using SK&F 96365 and LOE 908. Naunyn Schmiedebergs Arch Pharmacol 362: 160-168, 2000.[CrossRef][Web of Science][Medline]
  31. Tang J, Lin Y, Zhang Z, Tikunova S, Birnbaumer L, and Zhu MX. Identification of common binding sites for calmodulin and inositol 1,4,5-trisphosphate receptors on the carboxy termini of Trp channels. J Biol Chem 276: 21303-21310, 2001.[Abstract/Free Full Text]
  32. Tiruppathi C, Freichel M, Vogel SM, Paria BC, Mehta D, Flockerzi V, and Malik AB. Impairment of store-operated Ca2+ entry in TRPC4(-/-) mice interferes with increase in lung microvascular permeability. Circ Res 91: 70-76, 2002.[Abstract/Free Full Text]
  33. Trebak M, Vazquez G, Bird G, and Putney JW. The TRPC3/6/7 subfamily of cation channels. Cell Calcium 33: 451-461, 2003.[CrossRef][Web of Science][Medline]
  34. Walker RL, Hume JR, and Horowitz B. Differential expression and alternative splicing of TRP channel genes in smooth muscles. Am J Physiol Cell Physiol 280: C1184-C1192, 2001.[Abstract/Free Full Text]
  35. Welsh DG, Morielli AD, Nelson MT, and Brayden JE. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res 90: 248-250, 2002.[Abstract/Free Full Text]
  36. Xu SZ and Beech DJ. TrpC1 is a membrane-spanning subunit of store-operated Ca2+ channels in native vascular smooth muscle cells. Circ Res 88: 84-87, 2001.[Abstract/Free Full Text]
  37. Zhang L and Saffen D. Muscarinic acetylcholine receptor regulation of TRP6 Ca2+ channel isoforms. J Biol Chem 276: 13331-13339, 2001.[Abstract/Free Full Text]
  38. Zhang XF, Iwamuro Y, Okamoto Y, Kawanabe Y, Masaki T, and Miwa S. Endothelin-1-induced contraction of rat thoracic aorta depends on calcium entry through three types of calcium channel. J Cardiovasc Pharmacol 36, Suppl 1: S105-S106, 2000.[Web of Science][Medline]
  39. Zhang Z, Tang J, Tikunova S, Johnson JD, Chen Z, Qin N, Dietrich A, Stefani E, Birnbaumer L, and Zhu MX. Activation of Trp3 by inositol 1,4,5-trisphosphate receptors through displacement of inhibitory calmodulin from a common binding domain. Proc Natl Acad Sci USA 98: 3168-3173, 2001.[Abstract/Free Full Text]
  40. Zitt C, Halaszovich CR, and Luckhoff A. The TRP family of cation channels: probing and advancing the concepts on receptor-activated calcium entry. Prog Neurobiol 66: 243-264, 2002.[CrossRef][Web of Science][Medline]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
T. L. Thai, G. C. Churchill, and W. J. Arendshorst
NAADP receptors mediate calcium signaling stimulated by endothelin-1 and norepinephrine in renal afferent arterioles
Am J Physiol Renal Physiol, August 1, 2009; 297(2): F510 - F516.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
T. L. Thai and W. J. Arendshorst
Mice lacking the ADP ribosyl cyclase CD38 exhibit attenuated renal vasoconstriction to angiotensin II, endothelin-1, and norepinephrine
Am J Physiol Renal Physiol, July 1, 2009; 297(1): F169 - F176.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
S. Sours-Brothers, M. Ding, S. Graham, and R. Ma
Interaction Between TRPC1/TRPC4 Assembly and STIM1 Contributes to Store-Operated Ca2+ Entry in Mesangial Cells
Experimental Biology and Medicine, June 1, 2009; 234(6): 673 - 682.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
D. Liu, D. Yang, H. He, X. Chen, T. Cao, X. Feng, L. Ma, Z. Luo, L. Wang, Z. Yan, et al.
Increased Transient Receptor Potential Canonical Type 3 Channels in Vasculature From Hypertensive Rats
Hypertension, January 1, 2009; 53(1): 70 - 76.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
S. K. Fellner and W. J. Arendshorst
Angiotensin II-stimulated Ca2+ entry mechanisms in afferent arterioles: role of transient receptor potential canonical channels and reverse Na+/Ca2+ exchange
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F212 - F219.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
S. Graham, M. Ding, S. Sours-Brothers, T. Yorio, J.-X. Ma, and R. Ma
Downregulation of TRPC6 protein expression by high glucose, a possible mechanism for the impaired Ca2+ signaling in glomerular mesangial cells in diabetes
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1381 - F1390.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
R. Inoue, L. J. Jensen, J. Shi, H. Morita, M. Nishida, A. Honda, and Y. Ito
Transient Receptor Potential Channels in Cardiovascular Function and Disease
Circ. Res., July 21, 2006; 99(2): 119 - 131.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
S. Sours, J. Du, S. Chu, M. Ding, X. J. Zhou, and R. Ma
Expression of canonical transient receptor potential (TRPC) proteins in human glomerular mesangial cells
Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1507 - F1515.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
M. Goel, W. G. Sinkins, C.-D. Zuo, M. Estacion, and W. P. Schilling
Identification and localization of TRPC channels in the rat kidney
Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1241 - F1252.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
R. Ma, J. Du, S. Sours, and M. Ding
Store-Operated Ca2+ Channel in Renal Microcirculation and Glomeruli
Experimental Biology and Medicine, February 1, 2006; 231(2): 145 - 153.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. P. Winn, N. Daskalakis, R. F. Spurney, and J. P. Middleton
Unexpected Role of TRPC6 Channel in Familial Nephrotic Syndrome: Does It Have Clinical Implications?
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 378 - 387.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
C. S. Facemire and W. J. Arendshorst
Calmodulin mediates norepinephrine-induced receptor-operated calcium entry in preglomerular resistance arteries
Am J Physiol Renal Physiol, July 1, 2005; 289(1): F127 - F136.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
M. P. Winn, P. J. Conlon, K. L. Lynn, M. K. Farrington, T. Creazzo, A. F. Hawkins, N. Daskalakis, S. Y. Kwan, S. Ebersviller, J. L. Burchette, et al.
A Mutation in the TRPC6 Cation Channel Causes Familial Focal Segmental Glomerulosclerosis
Science, June 17, 2005; 308(5729): 1801 - 1804.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. A. Reading, S. Earley, B. J. Waldron, D. G. Welsh, and J. E. Brayden
TRPC3 mediates pyrimidine receptor-induced depolarization of cerebral arteries
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2055 - H2061.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
R. Ma, J. L. Pluznick, and S. C. Sansom
Ion Channels in Mesangial Cells: Function, Malfunction, or Fiction
Physiology, April 1, 2005; 20(2): 102 - 111.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Earley, B. J. Waldron, and J. E. Brayden
Critical Role for Transient Receptor Potential Channel TRPM4 in Myogenic Constriction of Cerebral Arteries
Circ. Res., October 29, 2004; 95(9): 922 - 929.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
D. J. Beech, K. Muraki, and R. Flemming
Non-selective cationic channels of smooth muscle and the mammalian homologues of Drosophila TRP
J. Physiol., September 15, 2004; 559(3): 685 - 706.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/3/F546    most recent
00338.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (37)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Facemire, C. S.
Right arrow Articles by Arendshorst, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Facemire, C. S.
Right arrow Articles by Arendshorst, W. J.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.